Rhelion Life Sciences Corp. TRUFF
0.01 USD 0.00 (+0.00%)
Regular-session close
0.0141 Day range 0.0141
0.011 52-week range 0.033
- YTD
- -12.50%
- 1 year
- -26.32%
News
newsfilecorp.com Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New United States Patent, Extending the Broadest Natural Psilocybin Patent Estate A new United States patent, "Psychoactive Alkaloid Extraction and Composition with Inhibited Dephosphorylation," has been issued by the United States Patent and Trademark Office, adding to the…
newsfilecorp.com Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to UCSF for Phase 1 Trial of Psilocybin in Healthy Older Adults with Low Well-Being Filament has shipped PEX010 to the University of California, San Francisco (UCSF) for OAD1, a Phase 1 trial of psilocybin in healthy older adults with low well-being. Toronto, Ontario--(Newsfile…
